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Background: Follow-up rate after a fecal occult blood test (FOBT) is low worldwide. In order to increase the follow-up
rate, segmentation of the target population has been proposed as a promising strategy, because an intervention can
then be tailored toward specific subgroups of the population rather than using one type of intervention for all groups.
The aim of this study is to identify subgroups that share the same patterns of characteristics related to follow-up exams
after FOBT.
Methods: The study sample consisted of 143 patients aged 50–69 years who were requested to undergo follow-up
exams after FOBT. A classification tree analysis was performed, using the follow-up rate as a dependent variable and
sociodemographic variables, psychological variables, past FOBT and follow-up exam, family history of colorectal cancer
(CRC), and history of bowel disease as predictive variables.
Results: The follow-up rate in 143 participants was 74.1% (n = 106). A classification tree analysis identified four
subgroups as follows; (1) subgroup with a high degree of fear of CRC, unemployed and with a history of
bowel disease (n = 24, 100.0% follow-up rate), (2) subgroup with a high degree of fear of CRC, unemployed
and with no history of bowel disease (n = 17, 82.4% follow-up rate), (3) subgroup with a high degree of fear of
CRC and employed (n = 24, 66.7% follow-up rate), and (4) subgroup with a low degree of fear of CRC (n = 78,
66.7% follow-up rate).
Conclusion: The identification of four subgroups with a diverse range of follow-up rates for CRC screening
indicates the direction to take in future development of an effective tailored intervention strategy.
Keywords: Colorectal neoplasms, Occult blood, Early detection of cancer, Patient compliance, Diagnostic
examination, Classification tree analysisBackground
Colorectal cancer (CRC) is the second leading cause of
cancer mortality in developed countries, with 727,400
new cancer cases and 320,100 deaths estimated to occur
worldwide in 2008 [1]. As five-year CRC mortality rates
vary according to the extent of tumor spread at the time
of diagnosis, early detection is important.
Screening using the fecal occult blood test (FOBT) has
been shown to reduce the incidence and mortality of
CRC [2-7]. However, the potential benefit of screening
for CRC has remained limited worldwide by failure to
follow-up after FOBT. While compliance rates in a clin-
ically controlled setting are over 80%, poor compliance* Correspondence: hrsaito@ncc.go.jp
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reproduction in any medium, provided the orrates ranging from around 30% to 70% have been reported
in non-experimental settings [8-24]. Therefore, it is par-
ticularly important to develop effective intervention strat-
egies to increase low post-FOBT follow-up rates.
Audience segmentation, which involves the identifica-
tion of population subgroups that share particular char-
acteristics, has been proposed as a promising strategy
because interventions can be tailored toward particular
subgroups [25-27]. Thus, segmenting the population
could better guide the development of effective inter-
vention strategies to increase follow-up compliance
after screening tests. Specifically, segmentation can as-
sist in the development of tailored interventions for
high-risk subgroups with low follow-up rates, which
have a high tendency to be undetected in existing mass
screening programs.l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Participation flow.
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subgroups of individuals who share the same patterns of
characteristics related to the follow-up exam after FOBT
and 2) to examine the variance among identified sub-
groups in order to develop effective tailored interventions.
Methods
Setting
The study was conducted in the Omiya district of
Saitama city in Saitama Prefecture adjunct to Tokyo,
Japan. The population was 108,585 as of January 1st,
2010. During the period of the study, it was the local
government’s policy to recommend an annual 2-day im-
munochemical FOBT screening for those aged 40 years
and over. The FOBT is provided through a local medical
association network of 170 clinics authorized by the
local government. The local government informs eligible
inhabitants about the screening once every year in April
through pamphlets that are mailed to each household.
Applicants then visit one of the 170 clinics to get the
FOBT kit containing printed instructions for specimen
collection and applicator sticks. Screening participants
were required to conduct the specimen collection at
home and to return the completed kits to the clinics.
Participants were asked to visit the clinic again two
weeks after undertaking the test to receive their diagnos-
tic results. In the case of a positive result, participants
were instructed by their physician to undertake add-
itional tests.
Procedure
Participants in this study were CRC screening partici-
pants recruited at the time they visited the clinic to get
the FOBT kits. We handed letters requesting participa-
tion in the study to participants aged in their 50s and
60s. After obtaining oral consent to participate in the
study, willing participants were asked to complete an an-
onymous questionnaire at home. The questionnaires
were returned by the participants when they returned
their FOBT kits to the clinic. The data collection period
was from September 2009 to March 2010. The total
number of CRC screening participants during the study
period was 12,009.
Participants
Figure 1 shows the participation flow. Of the 3,536 partici-
pants who received the mail survey, 2,222 (response rate:
62.8%) replied. Following the baseline survey, 143 partici-
pants, who were asked to undergo follow-up examinations,
were analyzed for the current study.
Survey measures
Survey measures included a follow-up exam after FOBT
as a dependent variable and sociodemographic variables,psychological variables, past FOBT and follow-up exam,
family history of CRC, and history of bowel disease as
predictive variables.Dependent variable
A follow-up exam after FOBT was employed as a dependent
variable in this study. The number of follow-up exams
was collected as a part of standard record-keeping of par-
ticipating facilities. Each facility sent written notifications
to the local government when a follow-up exam had been
performed. This information was used to determine the
number of follow-up exams.Predictive variables
Sociodemographic variables included age, sex, marital status,
education, employment status, and subjective economic
status.
The psychological variables used in this study were de-
rived from the constructs of the Health Belief Model
[28] and the Theory of Planned Behavior [29]. According
to the Health Belief Model, a person’s behavior is deter-
mined by the following four beliefs: (a) perceived suscep-
tibility, (b) perceived severity, (c) perceived barriers, and
(d) perceived benefits. A previous systematic review sug-
gested that the Health Belief Model is the most consist-
ent model to predict CRC screening behavior [30]. Also,
according to the Theory of Planned Behavior, a person’s
behavior is driven by his/her intention to perform the
behavior. For example, intention to undergo CRC screen-
ing has remained one of the strongest factors in past stud-
ies [31,32]. Accordingly, the psychological variables we
measured in this study were the perceived susceptibility
and severity of CRC, perceived benefits and barriers of
follow-up exam after FOBT, and intention to undergo a
follow-up exam. The measurements for these psycho-
logical variables were derived from a past study (see
Zheng et al. [33] for detailed questionnaire).
Family history of CRC was assessed as a dichotomous
(yes/no) variable with the statement “Have any of your
first-degree blood relatives had CRC?”




Follow-up exam 106 74.1
Socio-demographic
characteristics
Age 50–59 36 25.2
60–69 107 74.8
sex Male 63 44.1
Marital status Married 119 83.2
Education Less than high school 8 5.6




College degree or higher 39 27.3
Employment status Employed 54 37.8
Self-rated economic
status
Poor/Somewhat affluent 26 18.2
Average 98 68.5
Affluent/Somewhat affluent 19 13.3
Family history of CRC Yes 22 15.4
History of bowel disorder Yes 71 49.7




Past follow-up exam Yes 33 23.1
Psychographic
characteristics
Intention Yes 94 65.7
Perceived benefits 6–30 25.6 (3.6)
Perceived susceptibility 3–15 9.0 (2.7)
Perceived severity 6–30 21.3 (4.8)
Perceived barriers 13–65 38.7 (8.7)
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(yes/no) variable with the statement “Have you ever
undertaken an FOBT?” In addition, participants were
asked whether they had ever received positive FOBT re-
sults and undergone follow-up exams.
Statistical analysis
First, frequencies and percentages of measured variables
are reported. Next, a classification tree analysis is per-
formed in order to identify the best combination of the
measured variables that predict compliance with follow-
up exam after FOBT. Among multivariate statistical ana-
lyses, the classification tree analysis is suggested to be
superior to cluster analysis or the logistic regression ana-
lysis in identifying distinctive homogeneous subgroups
for further development of tailored intervention [34]. In
the current analysis, we adopted chi-square values as a
criterion for variable selection, and the groups were di-
vided into two groups until the following criteria were
met: (1) 10% or less of all participants after grouping or
(2) no significant explanatory variables at p < 0.001. The
outcome variable was follow-up exam after FOBT and
the explanatory variables were socio-demographic vari-
ables, psychological variables, past FOBT and follow-up
exam, family history of CRC, and history of bowel dis-
ease. Finally, in order to test differences between sub-
groups identified by classification tree analysis, ANOVA
was performed on continuous variables and a Chi-
square test on categorical variables. Measured variables
were statistically tested and p < 0.002 was adopted as sig-
nificance level by a Bonferroni correction. All analyses
were performed using SAS 9.1.3 (SAS Institute, Cary,
NC). Participants with missing data were excluded from
the analysis.
Ethical issues
This study was approved by the Institutional Review
Board (IRB) of the National Cancer Center in Japan and
adopted the principles of the Declaration of Helsinki.
Results
Baseline characteristics of respondents
Table 1 presents the characteristics of the study par-
ticipants. The follow-up rate after FOBT was 74.1%
(n = 106).
Classification tree analysis
Figure 2 shows the result of the classification tree ana-
lysis. For all participants, the most appropriate explana-
tory variable that predicts compliance with follow-up
exam after FOBT was fear of CRC. The was further clas-
sified into 2 groups: one with a high degree of fear of
CRC (n = 65, 83.1% follow-up rate) and one with a lowdegree of fear of CRC (n = 78, 66.7% follow-up rate).
The next most appropriate explanatory variable detected
in the subgroup with a high degree of fear of CRC was
employment status. This subgroup was further divi-
ded into two subgroups of unemployed (n = 41, 92.7%
follow-up rate) and employed individuals (n = 24, 66.7%
follow-up rate). On the other hand, for the subgroup
with a lower degree of fear of CRC, no appropriate ex-
planatory variable meeting the criteria was detected. Fi-
nally, the unemployed subgroup was divided into two
subgroups of individuals with a history of bowel disease
(n = 24, 100.0% follow-up rate) and those without a history
of bowel disease (n = 17, 82.4% follow-up rate). At that
point, the level of the criteria for the analysis completion
was reached.
Figure 2 Classification tree analysis of follow-up exam after fecal occult blood test.
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Table 2 shows the characteristics of each subgroup iden-
tified by the classification tree analysis. There were sta-
tistically significant differences between subgroups in the
following variables: sociodemographic variables such as
education (p = 0.001) and employment status (p < 0.001);
history of bowel disease (p < 0.001); and perceived sever-
ity (p < 0.001).
Discussion
In order to achieve the goal of reducing colorectal can-
cer morbidity and mortality by mass screening, it is im-
perative that patients receive timely and appropriate
follow-up exams for detected abnormalities. However,
low follow-up rates after FOBT limits the potential
benefit of mass CRC screening. Therefore, specifically
from a public health perspective, targeting high-risk sub-
groups with low follow-up rates (i.e. people who are
more likely to have CRC than the general public) is par-
ticularly important. This study is, to our knowledge, the
first study to identify subgroups that share the same pat-
terns of characteristics in terms of follow-up examina-
tions after FOBT.
The most important finding of the present study is the
identification of four subgroups with diverse follow-up
rates (ranging from 66.7% to 100.0%) using classifica-tion tree analysis. This method has been shown to be a
powerful medical decision-making tool [35]. Compared
with cluster analysis or logistic regression analysis, the
visual image of a hierarchical tree structure provides
benefit to clinical practitioners, because the choice of a
tailored message only depends on three questions: Fear
of CRC, employment status, and past history of bowel
disease.
A second implication is that fear of CRC, one of the
psychological variables of perceived severity based on the
Health Belief Model [28], has been demonstrated to have
the closest association with follow-up examinations. Through
selecting a combination of antecedent behavioral variables,
the value of behavioral theories should be considered, as
they could guide the development of effective intervention
strategies [36]. The current limited research on examining
the theory-based variables related to follow-up behavior
after FOBT therefore calls for further focused and pro-
spective research.
This study has several limitations. First, the sample size
(n = 143) was small, and therefore the statistical power
might be insufficient. Second, a selection bias should be
considered in lieu of a relatively low response rate of 62.8%.
Third, because the participants were recruited from a single
urban community, generalization of the findings should
be treated with caution. Fourth, not all confounders have
been accounted for. Efforts to reduce chances for produ-
Table 2 Comparison among identified subgroups by classification tree analysis
Group 1 Group 2 Group 3 Group 4
Variable Range or category % or mean (SD) % or mean (SD) % or mean (SD) % or mean (SD) p
Follow-up exam Yes 100 82.4 66.7 66.7 0.008
Socio-demographic characteristics
Age 50–59 20.8 23.5 33.3 24.4 0.767
60–69 79.2 76.5 66.7 75.6
Gender Male 29.2 35.3 41.7 51.3 0.222
Marital status Married 83.3 82.4 79.2 84.6 0.940
Education Less than high school 8.3 0.0 8.3 5.1 0.001
High school 58.3 58.8 37.5 50.0
Junior college/technical school 25.0 29.4 37.5 5.1
College degree or higher 8.3 11.8 16.7 39.7
Employment status Employed 0.0 0.0 100.0 38.5 <0.001
Self-rated economic status Poor/Somewhat affluent 16.7 29.4 8.3 19.2 0.309
Average 66.7 70.6 83.3 64.1
Affluent/Somewhat affluent 16.7 0.0 8.3 16.7
Family history of CRC Yes 8.3 17.7 16.7 16.7 0.774
History of bowel disease Yes 100.0 0.0 58.3 42.3 <0.001
Past FOBT screening Yes 87.5 94.1 83.3 87.2 0.786
Past follow-up recommendation Yes 20.8 29.4 29.2 21.8 0.809
Past follow-up exam Yes 20.8 29.4 29.2 20.5 0.743
Psychographic characteristics
Intention Yes 70.8 70.6 75.0 60.3 0.492
Perceived benefits 6–30 25.5 (3.3) 25.4 (4.0) 26.3 (3.3) 25.5 (3.8) 0.805
Perceived susceptibility 3–15 9.3 (2.7) 9.9 (3.0) 9.8 (3.2) 8.5 (2.4) 0.071
Perceived severity 6–30 24.3 (2.3) 24.8 (3.7) 25.2 (3.6) 18.5 (4.1) <0.001
Perceived barriers 13–65 39.8 (10.3) 42.3 (8.2) 39.1 (8.2) 37.4 (8.3) 0.175
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have been conducted as major confounders identified in
the previous studies and were controlled statistically.
Conclusions
We identified four subgroups of individuals who share
the same patterns of characteristics related to their degree
of compliance with the follow-up exam after FOBT. The
unique characteristics of each identified subgroup suggest
future development efforts to design an effective tailored
intervention strategy.
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